Assorted News from the Last Week: A large number of CAC2 members contributed to the recently published conclusions from the 2024 paediatric strategy forum for
In CAC2’s “Fit for Filing” webinar, our speakers explored designing and conducting academic or academic industry collaborative trials that produce data suitable for regulatory filing.
Assorted News from the Last Week: The U.S. Food and Drug Administration (FDA) approved FoundationOne®CDx as a companion diagnostic for Supporting Organization Member Day One
Assorted News from the Last Week: Pope Francis tells pediatric cancer patients they are ‘witnesses of hope.’ Unraveling the relationship between stress exposure and childhood
Assorted News from the Last Week: GLO-BNHL opens first sites of a multi-country platform trial that will offer multiple new treatments and a better chance
Assorted News from the Last Week: Spending package extends medicare telehealth flexibilities for three months and Gabriella Miller Kids First 2.0 reauthorization passes in standalone
Assorted News from the Last Week: Special Advocacy Call to Action: CAC2 Supporting Organization LLS is spearheading an effort and inviting all in the community
There were five pieces of legislation that had gained a lot of support across both the House and the Senate over the past two years
Assorted News from the Last Week: The simple act of asking young patients about their symptoms regularly during cancer treatment can help them get more
During our October federal advocacy drop-in session, we learned about several pieces of legislation that had a good chance to pass before the end of
